Viemed Healthcare US (DE:VIJ)
NASDAQ:VIJ
Earnings Data
Report Date
Aug 12, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.1Last Year’s EPS
0.07Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented strong operational and financial progress: revenue growth of 28% YoY, substantial free cash flow improvement, meaningful scaling in sleep (PAP up 57% YoY) and maternal health expansion, improved capital efficiency and a stronger, more diversified revenue mix. Near-term headwinds are largely related to NCD-driven compliance effects in ventilation (higher turnover and temporary pressure on net census), some seasonality, and comparability issues from a prior-year gain. Management reiterated positive guidance, tightened revenue guidance upward, and highlighted continued margin and cash-flow improvement, indicating confidence in execution.Company Guidance
Revenue Growth
Q1 revenue of $75.4 million, up 28% year-over-year and essentially flat sequentially vs Q4 2025 ($76.2M), consistent with expected seasonality.
Strong Free Cash Flow Improvement
Free cash flow of $2.6 million vs negative $5.7 million in prior year, an $8.3 million improvement; trailing twelve-month free cash flow increased to $36.3 million (from $23.3M through 2025 and $11.6M at end of 2024).
Sleep Business Momentum
PAP therapy patient count reached 35,938 (nearly 36,000), up 57% year-over-year and 4% sequentially; resupply patients up 47% year-over-year, driving recurring, predictable revenue.
Maternal Health Expansion and Integration
Lehan integration accretive since acquisition; serviced just under 4,000 new maternal health patients in markets where Lehan previously had no presence, demonstrating scalable platform leverage.
Diversifying Revenue Mix
Ventilator rentals were $35.4M (approx. 47% of revenue) vs 54% in 2025; other HME rentals $16.2M (+25% YoY); equipment & supply sales $17.5M, more than doubling from $7.5M, reducing concentration risk and improving capital efficiency.
Profitability and Margin Progress
Gross profit $42.8M with gross margin of 56.8% (vs 56.3% prior year); adjusted EBITDA $14.3M (19% of revenue). On a comparable basis (excluding a prior-year $2.7M gain), adjusted EBITDA margin expanded ~200 basis points year-over-year.
Operating Cash Flow & CapEx Efficiency
Operating cash flow $8.1M vs $2.9M prior year (nearly 3x); net CapEx $5.5M vs $8.5M prior year; updated full-year net CapEx outlook to 9.0%–10.5% of net revenue (from prior 10%–11.5%).
Strong Balance Sheet & Capital Returns
Ended quarter with $9.8M cash, $46M available credit, long-term debt reduced to $8.3M; repurchased and canceled 150,000 shares for $1.4M and made $3.2M principal debt payments.
Positive Operational Signals in Ventilation
New ventilator setup momentum ahead of expectations: March starts 759 vs 692 a year ago (+~9.7%); compliance among active ventilator patients improved nearly 20% since NCD implementation.
Guidance Update and Confidence
Raised low end of full-year net revenue guidance to $312M–$320M (from $310M–$320M) and reaffirmed adjusted EBITDA guidance of $65M–$69M; expect sequential revenue growth of ~3%–5% per quarter through year.
DE:VIJ Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:VIJ Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 05, 2026 | €7.80 | €7.25 | -7.05% |
Mar 04, 2026 | €7.35 | €7.45 | +1.36% |
Nov 05, 2025 | €5.40 | €5.30 | -1.85% |
Nov 05, 2025 | €5.40 | €5.30 | -1.85% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Viemed Healthcare US (DE:VIJ) report earnings?
Viemed Healthcare US (DE:VIJ) is schdueled to report earning on Aug 12, 2026, TBA (Confirmed).
What is Viemed Healthcare US (DE:VIJ) earnings time?
Viemed Healthcare US (DE:VIJ) earnings time is at Aug 12, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Viemed Healthcare US stock?
The P/E ratio of Viemed Healthcare is N/A.
What is DE:VIJ EPS forecast?
DE:VIJ EPS forecast for the fiscal quarter 2026 (Q2) is 0.1.
